Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas
Justin Z. Wang(University Health Network), Gelareh Zadeh(University Health Network), Zamir A Merali(University of Toronto), Mathew Voisin(University Health Network), Zeel Patel(University Health Network), Derek S. Tsang(University Health Network), Normand Laperrière(McGill University), David G. Muñoz(St. Michael's Hospital), Lauren Rogers(Princess Margaret Cancer Centre), Grace Lee(Boston Children's Hospital), Farshad Nassiri(University Health Network), Alexander Landry(Princess Margaret Cancer Centre), Jeffrey Zuccato(University of Oklahoma Health Sciences Center)
Cited by 8
Related Papers
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
|Acta Neuropathologica|2015|528
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
|Cancer Cell|2020|470
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
|Infection Control and Hospital Epidemiology|2014|425